BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10841197)

  • 21. Development of a risk stratification system to guide treatment for female germ cell tumors.
    Meisel JL; Woo KM; Sudarsan N; Eng J; Patil S; Jacobsen EP; Murali R; Gardner GJ; Bosl GJ; Aghajanian C; Feldman DR
    Gynecol Oncol; 2015 Sep; 138(3):566-72. PubMed ID: 26115974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
    Donohue JP; Thornhill JA; Foster RS; Bihrle R; Rowland RG; Einhorn LH
    J Urol; 1995 Jan; 153(1):85-9. PubMed ID: 7966799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis.
    Mohamed GH; Gelfond JA; Nicolas MM; Brand TC; Sarvis JA; Leach RJ; Johnson-Pais TL
    Urology; 2012 Aug; 80(2):485.e1-5. PubMed ID: 22503760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of clinical stage I nonseminomatous germ-cell testis tumors.
    Flechon A; Droz JP
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
    Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case for relevant staging of germ cell tumors.
    Logothetis CJ
    Cancer; 1990 Feb; 65(3 Suppl):709-17. PubMed ID: 2154316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testicular cancer at Kenyatta National Hospital, Nairobi.
    Opot EN; Magoha GA
    East Afr Med J; 2000 Feb; 77(2):80-5. PubMed ID: 10774080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
    Li R; Li H
    BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postchemotherapy changes in testicular germ cell tumours: biology and morphology.
    Berney DM; Lu YJ; Shamash J; Idrees M
    Histopathology; 2017 Jan; 70(1):26-39. PubMed ID: 27960240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumors of the Testis: Morphologic Features and Molecular Alterations.
    Howitt BE; Berney DM
    Surg Pathol Clin; 2015 Dec; 8(4):687-716. PubMed ID: 26612222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
    Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on testicular germ cell tumors.
    Nallu A; Chimakurthi R; Hussain A; Mannuel HD
    Curr Opin Oncol; 2014 May; 26(3):294-8. PubMed ID: 24675234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
    Margolin K
    J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.